A detailed history of Bridgeway Capital Management, LLC transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 293,500 shares of XTNT stock, worth $137,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares
293,500
Previous 293,500 -0.0%
Holding current value
$137,945
Previous $184,000 8.15%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.03 $47,250 - $77,250
-75,000 Reduced 20.35%
293,500 $184,000
Q4 2023

Feb 14, 2024

BUY
$1.04 - $1.39 $208,000 - $278,000
200,000 Added 118.69%
368,500 $416,000
Q3 2023

Nov 14, 2023

BUY
$0.78 - $1.35 $42,120 - $72,900
54,000 Added 47.16%
168,500 $185,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.72 $106,950 - $167,400
-232,500 Reduced 67.0%
114,500 $82,000
Q1 2022

May 16, 2022

SELL
$0.57 - $0.88 $14,249 - $22,000
-25,000 Reduced 6.72%
347,000 $236,000
Q4 2021

Feb 14, 2022

SELL
$0.56 - $1.26 $69,384 - $156,114
-123,900 Reduced 24.98%
372,000 $208,000
Q3 2021

Nov 15, 2021

BUY
$1.05 - $2.0 $215,247 - $409,996
204,998 Added 70.47%
495,900 $550,000
Q2 2021

Aug 16, 2021

SELL
$1.38 - $2.46 $112,329 - $200,239
-81,398 Reduced 21.86%
290,902 $474,000
Q1 2021

May 17, 2021

BUY
$1.23 - $4.33 $273,429 - $962,559
222,300 Added 148.2%
372,300 $879,000
Q4 2020

Feb 16, 2021

BUY
$0.82 - $1.63 $20,500 - $40,750
25,000 Added 20.0%
150,000 $179,000
Q3 2020

Nov 16, 2020

SELL
$0.76 - $1.6 $35,656 - $75,065
-46,916 Reduced 27.29%
125,000 $103,000
Q2 2020

Aug 14, 2020

BUY
$0.62 - $1.74 $75,587 - $212,133
121,916 Added 243.83%
171,916 $155,000
Q2 2018

Aug 14, 2018

BUY
$5.33 - $8.31 $266,500 - $415,500
50,000 New
50,000 $278,000

Others Institutions Holding XTNT

About Xtant Medical Holdings, Inc.


  • Ticker XTNT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 108,226,000
  • Market Cap $50.9M
  • Description
  • Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...
More about XTNT
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.